Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.
about
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapyProphylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapyAntibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapyFever and neutropenia in pediatric hematopoietic stem cell transplant patients.Fluoroquinolone use and Clostridium difficile-associated diarrhea.Opportunistic infections after blood and marrow transplantation.Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis.Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxisLack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants.Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation.Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and OncolOral antimicrobial prophylaxis in bone marrow transplant recipients: randomized trial of ciprofloxacin versus ciprofloxacin-vancomycin.Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation.Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome.Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia.Infections during mobilizing chemotherapy and following autologous stem cell transplantation.Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today?A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant.
P2860
Q24203869-9313179C-98A3-42CD-B08E-4DC43C042C78Q24241680-F880EDD2-681F-41B9-B553-7A7A6D529BF9Q24245774-6B3593F8-AD41-4C72-9965-4BD1A839D4E1Q33827584-8608F8B5-5491-4199-98A4-025DB7A84E2CQ34202065-B552D564-C283-4FC8-B5A5-164D5C78E6FBQ34294774-449212BF-8AB0-4877-BB1D-68169FEC763FQ34461701-7AB95905-58F9-4901-B8E0-0E7A892DE46FQ34830063-0FDD1736-4DA5-48F0-A461-A68AA5F2BADBQ35122694-412D4E6B-49AE-4B0F-B7A0-2C8BC8699801Q35136336-4548D844-BB15-4887-BF52-62E9CB385CF3Q35920640-DE506BC3-D64B-4FAE-A59C-E6B78E514B98Q35937307-76C15B7F-DED0-447D-A771-D8D399390329Q36906212-54C4128B-C628-414F-9E0D-43AFA238B5F8Q38081793-DAD38030-B1F8-42BA-96E5-997C2BD6C58EQ39557711-6A642977-B341-402E-BF05-7E1AC3AB7E6DQ40545174-33879F3F-CAB4-4556-AD40-E6D5367D7800Q40545180-7674FA6F-4C39-4D10-95A7-D3394581ED37Q40592915-12929947-F40F-404C-BAF5-C4FFDCFE1A43Q43650913-6D169054-EE09-4180-B5FE-A382DB85B361Q43861734-0EE09918-FF58-41A0-9545-24B10CD1F1FFQ47709323-687397A4-5972-4B87-BC89-C39E6F437FDAQ52738699-B8A06EDC-268E-47A1-9CCC-30B75E39996C
P2860
Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Ciprofloxacin versus trimethop ...... randomized, controlled trial.
@en
type
label
Ciprofloxacin versus trimethop ...... randomized, controlled trial.
@en
prefLabel
Ciprofloxacin versus trimethop ...... randomized, controlled trial.
@en
P2093
P1476
Ciprofloxacin versus trimethop ...... randomized, controlled trial.
@en
P2093
K H Antman
L A Kalish
P304
P356
10.1200/JCO.1995.13.1.239
P407
P577
1995-01-01T00:00:00Z